summari report result exceed
street expect rais sale ep outlook
compani report ep ahead consensu
forecast guidanc underli
sale growth exceed guidanc flat ep beat
vs model primarili reflect higher revenu lower opex
lower tax rate rais underli sale growth guidanc
impli growth acceler
ep guidanc also increas
gener believ
compani start strong note updat
guidanc suggest growth momentum improv
year progress believ manag upbeat outlook
bode well may analyst day believ
could rais financi target rais ep
estim
sale growth outlook rais base out-performance
delay cyclophosphamid competit includ
product acquisit rais oper sale growth
year growth expect
impli growth growth acceler
driven primarili easier comp relat hurrican maria
estim headwind tailwind
well launch version spectrum pump us ou
pump launch continu ramp large-volum iv solut
ou suppli busi rais oper sale growth
medic deliveri acut
therapi updat guidanc assum entri addit
cyclophosphamid competit potenti entri
brevibloc competit start gener supran
competit
ep guidanc also increas ep beat
improv sale growth outlook year also boost
ep guidanc
out-performance contribut full year ep rais delay
cyclophosphamid competit addit product
expect add full year earn despit increas
commod cost margin headwind increas gener
cyclosphosphamid competit expect gross margin
improv rest full
year basi compani continu expect yr/yr
oper margin improv compar increas
continu next page
pleas see page rate definit import disclosur
requir analyst certif estimates/forecast
well fargo secur llc seek busi compani
cover research report result investor awar
firm may conflict interest could affect object report
investor consid report singl factor make
compani data secur llc estim reuter
adjust spin-off baxalta
compani prioriti stock list
compani data secur llc estim reuter
continu previou page
sourc potenti upsid rais guidanc given bax histori guid conserv
execut track record could see upsid bax outlook area potenti
upsid includ delay addit gener cyclophosphamid competit alreadi rais
sale ep base absenc new competit ytd believ brevibloc
could repres addit upsid potenti gener competit delay and/or competitor calcium
channel blocker suppli issu unresolv
sale ep beat report ep beat consensu
estim ep beat vs model primarili reflect higher total revenu lower opex due time
vs estim lower tax rate vs estim partli off-set
lower gross margin vs estim total revenu ahead
consensu estim underli growth exclud fx clari
cyclophosphamid competit consist growth guidanc flat
expect revenu includ headwind due hurrican maria busi key
outperform includ acut therapi underli includ benefit strong flu
season pharmaceut underli strong inject perform advanc surgeri
underli slightli lower gross margin reflect underli yr/yr improv off-set
headwind hurrican maria fx well higher suppli chain/freight cost tax
reflect stock compens account benefit
expect financi outlook improv analyst day hold bi-annu analyst day
may nyc event compani showcas grow portfolio product includ
pipelin opportun expect launch next year addit expect
manag updat financi target like provid aspir financi outlook
call updat outlook sale compound-annual-growth-rate includ
clari oper margin ep free cash-flow rais
guidanc see strong likelihood improv financi outlook analyst day note
street alreadi forecast ep ahead compani goal
price target nc
price target base equal weight ev/ebtida dcf price-to-earnings risk
thesi includ unexpect competit headwind could slow restructur effort signific delay new
believ acceler sale growth expand oper margin consist deliv
reliabl low double-digit ep growth strong balanc sheet could enhanc long-term growth
baxter global medic product compani focus hospit product renal compani
report sale billion ex-fx growth
statement fy end dec million except per share revenu report structur -- hospit product gross gross tsa transit svc agreement sg total oper oper net interest incom expens incom expens total non-op incom expens pre-tax incom tax expens net adjust share outstand marginsgross ex-msa changetot share compani report secur llc estim medic technolog
